Most men who are treated for prostate cancer according to modern guidelines have good survival rates and the majority of ...

Charlottesville, Va.-based UVA Health is expanding its Stay in the Game initiative, a targeted prostate cancer screening program aimed at boosting early detection among Black men. Speaking with Becker ...

Most men who are treated for prostate cancer according to modern guidelines have good survival rates and the majority of these men will die of causes ...

A new population-level study from Uppsala University has found that most men treated for non-metastatic prostate cancer ...

New research published in the July 2025 issue of JNCCN—Journal of the National Comprehensive Cancer Network offers encouraging news for men diagnosed with nonmetastatic prostate cancer.

Novartis shares climb on strong Cosentyx sales, franchise growth, and a new malaria drug approval despite political risks.

During a live event, Jahan Aghalar, MD, discussed key NCCN-recommended oral therapies and landmark trials for metastatic ...

New research in the July 2025 issue of JNCCN-Journal of the National Comprehensive Cancer Network finds that for people diagnosed with nonmetastatic low-risk prostate cancer later in life, and treated ...

An expert discusses how the PEACE III combination of radium-223 and enzalutamide represents an effective treatment option for the limited population of patients who reach first-line metastatic ...

Pfizer and Astellas’ Xtandi (enzalutamide) has improved overall survival (OS) in patients with nmHSPC, but only as a combination therapy.

A local cancer survivor, Robert Dames, has released a new book titled "Cancer - What Now" to assist others in navigating the ...

Bob Lane discusses his experience with prostate cancer, and describes what survivorship and cure means to him as someone ...